| http://www.w3.org/ns/prov#value | - Study 4 was a placebo-controlled, randomized trial designed to assess the safety of Kineret?? in 1414 patients receiving a variety of concurrent medications for their RA including some DMARD therapies, as well as patients who were DMARD-free.
|